$SDGR has received five mentions from three distinct FinTwit voices over the past 12 months, with the first mention appearing on 2025-08-14. Jacob Plieth (@jacobplieth) is the most active voice discussing the stock, accounting for four of the five mentions, while InvestmentGuru (@investmentguru_) and Jon Erlichman (@jonerlichman) each contributed one mention. The biotech category dominates discussion of $SDGR among these voices. The most recent mention occurred on 2026-03-18, where Plieth included the ticker in a discussion of AACR26 conference presentations alongside other pharmaceutical and biotech stocks.